Dean G. Tang - Publications

The University of Texas Graduate School of Biomedical Sciences at Houston 
Cell Biology, Oncology

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Li Q, Deng Q, Chao HP, Liu X, Lu Y, Lin K, Liu B, Tang GW, Zhang D, Tracz A, Jeter C, Rycaj K, Calhoun-Davis T, Huang J, Rubin MA, ... ... Tang DG, et al. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nature Communications. 9: 3600. PMID 30190514 DOI: 10.1038/s41467-018-06067-7  0.48
2018 Tomida J, Takata KI, Bhetawal S, Person MD, Chao HP, Tang DG, Wood RD. FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells. The Embo Journal. PMID 29789392 DOI: 10.15252/embj.201899543  0.4
2017 Zhang D, Jeter C, Gong S, Tracz A, Lu Y, Shen J, Tang DG. Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration. Stem Cell Reports. PMID 29276153 DOI: 10.1016/j.stemcr.2017.11.016  0.44
2017 Rycaj K, Li H, Zhou J, Chen X, Tang DG. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Seminars in Cancer Biology. PMID 28408152 DOI: 10.1016/j.semcancer.2017.03.009  0.36
2017 Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer. Stem Cells Translational Medicine. 6: 748-760. PMID 28297567 DOI: 10.5966/sctm.2016-0243  0.48
2016 Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, ... Tang DG, et al. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discovery. 2: 16041. PMID 27867534 DOI: 10.1038/celldisc.2016.41  0.48
2016 Zhang D, Lin K, Lu Y, Rycaj K, Zhong Y, Chao HP, Calhoun-Davis T, Shen J, Tang DG. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer. Stem Cells Translational Medicine. PMID 27686757 DOI: 10.5966/sctm.2016-0243  0.48
2016 Liu R, Liu C, Zhang D, Liu B, Chen X, Rycaj K, Jeter C, Calhoun-Davis T, Li Y, Yang T, Wang J, Tang DG. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Oncotarget. PMID 27447749 DOI: 10.18632/oncotarget.10652  0.48
2016 Atanassov BS, Mohan RD, Lan X, Kuang X, Lu Y, Lin K, McIvor E, Li W, Zhang Y, Florens L, Byrum SD, Mackintosh SG, Calhoun-Davis T, Koutelou E, Wang L, ... Tang DG, et al. ATXN7L3 and ENY2 Coordinate Activity of Multiple H2B Deubiquitinases Important for Cellular Proliferation and Tumor Growth. Molecular Cell. PMID 27132940 DOI: 10.1016/j.molcel.2016.03.030  0.48
2016 Chen X, Li Q, Liu X, Liu C, Liu R, Rycaj K, Zhang D, Liu B, Jeter C, Calhoun-Davis T, Lin K, Lu Y, Chao HP, Shen J, Tang DG. Defining a population of stem-like human prostate cancer cells that can generate and propagate castration-resistant prostate cancer (CRPC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27060154 DOI: 10.1158/1078-0432.CCR-15-2956  0.48
2016 Zhang D, Park D, Zhong Y, Lu Y, Rycaj K, Gong S, Chen X, Liu X, Chao HP, Whitney P, Calhoun-Davis T, Takata Y, Shen J, Iyer VR, Tang DG. Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nature Communications. 7: 10798. PMID 26924072 DOI: 10.1038/ncomms10798  0.48
2015 Tang DG. Cancers of the breast and prostate: a stem cell perspective. Endocrine-Related Cancer. 22: E9-E11. PMID 26487552 DOI: 10.1530/ERC-15-0427  0.48
2015 Deng Q, Tang DG. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications. Endocrine-Related Cancer. 22: T209-20. PMID 26285606 DOI: 10.1530/ERC-15-0217  0.48
2015 Liu X, Chen X, Rycaj K, Chao HP, Deng Q, Jeter C, Liu C, Honorio S, Li H, Davis T, Suraneni M, Laffin B, Qin J, Li Q, Yang T, ... ... Tang DG, et al. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. PMID 26246472 DOI: 10.18632/oncotarget.4260  0.48
2015 Gong S, Li Q, Jeter CR, Fan Q, Tang DG, Liu B. Regulation of NANOG in cancer cells. Molecular Carcinogenesis. PMID 26013997 DOI: 10.1002/mc.22340  0.48
2015 Jeter CR, Yang T, Wang J, Chao HP, Tang DG. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions. Stem Cells (Dayton, Ohio). PMID 25821200 DOI: 10.1002/stem.2007  0.48
2014 Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Research. 74: 4183-95. PMID 24903149 DOI: 10.1158/0008-5472.CAN-14-0404  0.48
2014 Liu B, Badeaux MD, Choy G, Chandra D, Shen I, Jeter CR, Rycaj K, Lee CF, Person MD, Liu C, Chen Y, Shen J, Jung SY, Qin J, Tang DG. Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species. Plos One. 9: e90615. PMID 24598770 DOI: 10.1371/journal.pone.0090615  0.48
2013 Badeaux MA, Jeter CR, Gong S, Liu B, Suraneni MV, Rundhaug J, Fischer SM, Yang T, Kusewitt D, Tang DG. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals. Cell Cycle (Georgetown, Tex.). 12: 2395-408. PMID 23839044 DOI: 10.4161/cc.25402  0.48
2013 Chen X, Liu B, Li Q, Honorio S, Liu X, Liu C, Multani AS, Calhoun-Davis T, Tang DG. Dissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice. Plos One. 8: e56903. PMID 23451107 DOI: 10.1371/journal.pone.0056903  0.48
2013 Gogada R, Yadav N, Liu J, Tang S, Zhang D, Schneider A, Seshadri A, Sun L, Aldaz CM, Tang DG, Chandra D. Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. The Journal of Biological Chemistry. 288: 368-81. PMID 23152504 DOI: 10.1074/jbc.M112.386102  0.48
2012 Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, ... Tang DG, et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell. 10: 556-69. PMID 22560078 DOI: 10.1016/j.stem.2012.03.009  0.48
2012 Tang DG. Understanding cancer stem cell heterogeneity and plasticity Cell Research. 22: 457-472. PMID 22357481 DOI: 10.1038/cr.2012.13  0.48
2011 Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DG. Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. Plos One. 6: e24397. PMID 21935404 DOI: 10.1371/journal.pone.0024397  0.48
2011 Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Medicine. 17: 211-5. PMID 21240262 DOI: 10.1038/nm.2284  0.48
2010 Jiang M, Strand DW, Fernandez S, He Y, Yi Y, Birbach A, Qiu Q, Schmid J, Tang DG, Hayward SW. Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells. Stem Cells (Dayton, Ohio). 28: 344-56. PMID 20020426 DOI: 10.1002/stem.284  0.48
2009 Chandra D, Tang DG. Detection of apoptosis in cell-free systems. Methods in Molecular Biology (Clifton, N.J.). 559: 65-75. PMID 19609749 DOI: 10.1007/978-1-60327-017-5_5  0.48
2009 Li H, Jiang M, Honorio S, Patrawala L, Jeter CR, Calhoun-Davis T, Hayward SW, Tang DG. Methodologies in assaying prostate cancer stem cells. Methods in Molecular Biology (Clifton, N.J.). 568: 85-138. PMID 19582423 DOI: 10.1007/978-1-59745-280-9_7  0.48
2009 Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells (Dayton, Ohio). 27: 993-1005. PMID 19415763 DOI: 10.1002/stem.29  0.48
2009 Chen X, Schneider-Broussard R, Hollowell D, McArthur M, Jeter CR, Benavides F, DiGiovanni J, Tang DG. Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice. Differentiation; Research in Biological Diversity. 77: 324-34. PMID 19272531 DOI: 10.1016/j.diff.2008.10.011  0.48
2008 Bhatia B, Jiang M, Suraneni M, Patrawala L, Badeaux M, Schneider-Broussard R, Multani AS, Jeter CR, Calhoun-Davis T, Hu L, Hu J, Tsavachidis S, Zhang W, Chang S, Hayward SW, ... Tang DG, et al. Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells. The Journal of Biological Chemistry. 283: 27957-72. PMID 18662989 DOI: 10.1074/jbc.M803467200  0.48
2008 Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Research. 68: 1820-5. PMID 18339862 DOI: 10.1158/0008-5472.CAN-07-5878  0.48
2008 Bhatia B, Multani AS, Patrawala L, Chen X, Calhoun-Davis T, Zhou J, Schroeder L, Schneider-Broussard R, Shen J, Pathak S, Chang S, Tang DG. Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERT. International Journal of Cancer. Journal International Du Cancer. 122: 1483-95. PMID 18059027 DOI: 10.1002/ijc.23222  0.48
2007 Chandra D, Choy G, Tang DG. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. The Journal of Biological Chemistry. 282: 31289-301. PMID 17823127 DOI: 10.1074/jbc.M702777200  0.44
2007 Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Research. 67: 6796-805. PMID 17638891 DOI: 10.1158/0008-5472.CAN-07-0490  0.48
2007 Tang DG, Bhatia B, Tang S, Schneider-Broussard R. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins & Other Lipid Mediators. 82: 135-46. PMID 17164141 DOI: 10.1016/j.prostaglandins.2006.05.022  0.48
2007 Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Molecular Carcinogenesis. 46: 1-14. PMID 16921491 DOI: 10.1002/mc.20255  0.48
2006 Chandra D, Bratton SB, Person MD, Tian Y, Martin AG, Ayres M, Fearnhead HO, Gandhi V, Tang DG. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome. Cell. 125: 1333-46. PMID 16814719 DOI: 10.1016/j.cell.2006.05.026  0.48
2006 Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 25: 1696-708. PMID 16449977 DOI: 10.1038/sj.onc.1209327  0.48
2005 Choy G, Liu JW, Chandra D, Tang DG. Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. ProgrèS Des Recherches Pharmaceutiques. 63: 115-45. PMID 16265879  0.44
2005 Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Research. 65: 6207-19. PMID 16024622 DOI: 10.1158/0008-5472.CAN-05-0592  0.48
2005 Chandra D, Choy G, Daniel PT, Tang DG. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. The Journal of Biological Chemistry. 280: 19051-61. PMID 15757910 DOI: 10.1074/jbc.M501391200  0.44
2005 Bhatia B, Tang S, Yang P, Doll A, Aumüeller G, Newman RA, Tang DG. Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells. Oncogene. 24: 3583-95. PMID 15750631 DOI: 10.1038/sj.onc.1208406  0.48
2005 Liu JW, Chandra D, Rudd MD, Butler AP, Pallotta V, Brown D, Coffer PJ, Tang DG. Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene. 24: 2020-31. PMID 15674333 DOI: 10.1038/sj.onc.1208385  0.4
2004 Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG. Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Molecular and Cellular Biology. 24: 6592-607. PMID 15254227 DOI: 10.1128/MCB.24.15.6592-6607.2004  0.48
2004 Tang S, Bhatia B, Zhou J, Maldonado CJ, Chandra D, Kim E, Fischer SM, Butler AP, Friedman SL, Tang DG. Evidence that Sp1 positively and Sp3 negatively regulate and androgen does not directly regulate functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) gene expression in normal human prostate epithelial cells. Oncogene. 23: 6942-53. PMID 15247906 DOI: 10.1038/sj.onc.1207913  0.48
2003 Bhatia B, Maldonado CJ, Tang S, Chandra D, Klein RD, Chopra D, Shappell SB, Yang P, Newman RA, Tang DG. Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants. The Journal of Biological Chemistry. 278: 25091-100. PMID 12704195 DOI: 10.1074/jbc.M301920200  0.48
2003 Liu JW, Shen JJ, Tanzillo-Swarts A, Bhatia B, Maldonado CM, Person MD, Lau SS, Tang DG. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene. 22: 1475-85. PMID 12629510 DOI: 10.1038/sj.onc.1206196  0.48
2003 Chandra D, Tang DG. Mitochondrially localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the organelle. Lack of evidence for Apaf-1-mediated procaspase-9 activation in the mitochondria. The Journal of Biological Chemistry. 278: 17408-20. PMID 12611882 DOI: 10.1074/jbc.M300750200  0.48
2002 Chandra D, Liu JW, Tang DG. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. The Journal of Biological Chemistry. 277: 50842-54. PMID 12407106 DOI: 10.1074/jbc.M207622200  0.4
2002 Tang DG, La E, Kern J, Kehrer JP. Fatty acid oxidation and signaling in apoptosis. Biological Chemistry. 383: 425-42. PMID 12033433 DOI: 10.1515/BC.2002.046  0.48
2002 Liu JW, Chandra D, Tang SH, Chopra D, Tang DG. Identification and characterization of Bimgamma, a novel proapoptotic BH3-only splice variant of Bim. Cancer Research. 62: 2976-81. PMID 12019181  0.4
2002 Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, Zhau HE, Chung LW, Tang DG. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. The Journal of Biological Chemistry. 277: 16189-201. PMID 11839751 DOI: 10.1074/jbc.M111936200  0.48
Show low-probability matches.